GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Price-to-Funds-From-Operations

Adimmune (TPE:4142) Price-to-Funds-From-Operations : (As of Jan. 18, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Adimmune Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Adimmune Business Description

Industry
Traded in Other Exchanges
N/A
Address
Tanxing Road, No. 3, Sector 1, Tanzi District, Taichung, TWN, 427003
Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.